CD4 T Cell Anergy in Murine AIDS - Girija Muralidhar

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Cancer Institute (NCI)
Type: First Independent Research Support & Transition (FIRST) Awards (R29)
Project #: 7R29CA066523-03
Application #: 2376955
Study Section: AIDS and Related Research Study Section 1 (ARRA)

Project Start: 1994-07-01
Project End: 1997-02-28
Budget Start: 1996-11-15
Budget End: 1997-02-28
Support Year: 3
Fiscal Year: 1996
Total Cost
Indirect Cost

Institution

Name: Trudeau Institute, Inc.
Department
Type
DUNS #

City: Saranac Lake
State: NY
Country: United States
Zip Code: 12983

Related projects


NIH 1999 R29 CA	CD4 T Cell Anergy in Murine AIDS Muralidhar, Girija / Sidney Kimmel Cancer Center
NIH 1998 R29 CA	CD4 T Cell Anergy in Murine AIDS Muralidhar, Girija / Sidney Kimmel Cancer Center
NIH 1997 R29 CA	CD4 T Cell Anergy in Murine AIDS Muralidhar, Girija / Sidney Kimmel Cancer Center
NIH 1996 R29 CA	CD4 T Cell Anergy in Murine AIDS Muralidhar, Girija / University of California San Diego
NIH 1996 R29 CA	CD4 T Cell Anergy in Murine AIDS Muralidhar, Girija / Trudeau Institute, Inc.
NIH 1994 R29 CA	CD4 T Cell Anergy in Murine AIDS Muralidhar, Girija / University of California San Diego

Publications

Andrews, C; Swain, S L; Muralidhar, G (1997) CD4 T cell anergy in murine AIDS: costimulation via CD28 and the addition of IL-12 are not sufficient to rescue anergic CD4 T cells. J Immunol 159:2132-8

Muralidhar, G; Koch, S; Broome, H E et al. (1996) TCR triggering of anergic CD4 T cells in murine AIDS induces apoptosis rather than cytokine synthesis and proliferation. J Immunol 157:625-35

Comments

Be the first to comment on Girija Muralidhar's grant